• LAST PRICE
    1.8000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.6200/ 1
  • Ask / Lots
    1.9500/ 10
  • Open / Previous Close
    1.8100 / 1.8000
  • Day Range
    Low 1.7700
    High 1.8880
  • 52 Week Range
    Low 1.6100
    High 8.0400
  • Volume
    12,789
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.83
TimeVolumeICAD
09:32 ET2361.81
09:35 ET2251.888
09:37 ET1001.88
10:02 ET7101.8355
10:11 ET1001.78
10:15 ET30001.8399
10:29 ET7001.83
10:31 ET1001.77
11:18 ET6001.81
11:20 ET1251.7985
11:38 ET2001.8028
12:06 ET1001.79
12:33 ET2881.7972
12:35 ET20451.81
12:37 ET1001.805
12:44 ET1001.805
12:51 ET2001.81
12:53 ET1561.81
01:00 ET2481.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesICAD
ICAD Inc
45.8M
-3.1x
---
United StatesLNSR
LENSAR Inc
38.5M
-1.6x
---
United StatesEAR
Eargo Inc
22.0M
-0.1x
---
United StatesSSKN
STRATA Skin Sciences Inc
30.5M
-4.9x
---
United StatesAAXT
Aamaxan Transport Group Inc
20.0
0.0x
---
United StatesTTOO
T2 Biosystems Inc
13.0M
-0.1x
---
As of 2022-11-28

Company Information

iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

Contact Information

Headquarters
98 Spit Brook Rd Ste 100NASHUA, NH, United States 03062-5737
Phone
603-882-5200
Fax
603-880-3843

Executives

Independent Chairman of the Board
Timothy Irish
President, Chief Executive Officer, Director
Stacey Stevens
Interim Chief Financial Officer
Stephen Sarno
Chief Technology Officer
Jonathan Go
Chairman of the Board
Michael Klein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$45.8M
Revenue (TTM)
$29.3M
Shares Outstanding
25.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-0.58
Book Value
$1.85
P/E Ratio
-3.1x
Price/Sales (TTM)
1.6
Price/Cash Flow (TTM)
---
Operating Margin
-50.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.